Steini: "About $US 60m mc and on its way to cure many or maybe even all cancer, how undervalued by the Aussie market."
Steini/others: I agree with you, Steini, that IMU seems to be way, way undervalued! You blame this on the Aussie market (and I tend to agree that the ASX is not valuing biotech stocks like for instance the US market does).
However, with the exposure that Imugene is getting with their different presentation efforts outside of Australia, that famous "penny should drop" event or moment should be happening eventually and money from outside Australia should flow into this share??
Or is the only way forward a second listing outside of Australia perhaps (not that I think that this will really be necessary)??
Comments most welcome as usual.
wasa
Leslie Chong Interview at Biotech Showcase, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.001(2.63%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.7¢ | $268.8K | 7.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1165360 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 742337 | 6 |
View Market Depth
| Last trade - 11.35am 27/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
